IGF2BP3 and gastric cancer: In this study, we comprehensively investigated the effects of m6A reader protein IGF2BP3 on the malignant biological behavior of GC and elucidated its molecular mechanism and propose that IGF2BP3 may be a novel therapeutic target for GC progression.